# CRISPR Therapeutics AG > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v3 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Canonical entity | alpha:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/crispr-therapeutics-ag | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 19 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-15T20:38:02.503876+00:00 | | Last reviewed | 2026-09-15T20:38:02.503876+00:00 | ## Identity - Legal name: CRISPR Therapeutics AG - Display name: CRISPR Therapeutics AG ## Leadership - Ali Behbahani, M.D.: Director. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2. - Briggs W. Morrison, M.D.: Director. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2. - Christian Rommel, Ph.D.: Director. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2. - Douglas A. Treco, Ph.D.: Director. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2. - H. Edward Fleming, Jr., M.D.: Director. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2. - John T. Greene: Director. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2. - Katherine A. High, M.D.: Director. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2. - Maria Fardis, Ph.D.: Director. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2. - Samarth Kulkarni, Ph.D.: Director. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2. - Sandesh Mahatme, LL.M.: Director. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2. - Simeon J. George, M.D.: Director. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2. - James R. Kasinger: General Counsel and Secretary. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:3. - Naimish Patel, M.D.: Chief Medical Officer. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:3. - Raju Prasad, Ph.D.: Chief Financial Officer. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:3. - Samarth Kulkarni, Ph.D.: Chief Executive Officer. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:3. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - CRISPR Therapeutics AG. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:1. ## Headquarters - US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review. ## Entity Status - Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:1. ## Published Fact - US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:1. - Healthcare. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/crispr-therapeutics-ag). - alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:2: [CRISPR Therapeutics DEF 14A 2026-04-21](https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm). - alpha:evidence:company:e3ebab8b-2d79-43d4-90f4-8ca0fbfed5f4:3: [CRSP DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1674416/000119312526165158/crsp-20260421.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. - Current index memberships: Unavailable - Index membership events: Unavailable ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/crispr-therapeutics-ag) - [Public Markdown](https://registry.alpha.ac/companies/crispr-therapeutics-ag.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag) - [JSON-LD](https://registry.alpha.ac/api/public/companies/crispr-therapeutics-ag?format=jsonld) - MCP resource: `alpha://companies/crispr-therapeutics-ag` at https://mcp.alpha.ac/mcp